50 plum new grants from HHMI

Written byBrendan Maher

| 1 min read

Howard Hughes Medical Institute is opening a new competition for US investigators. It plans to fund as many as 50 new researchers by Spring 2008 representing an investment of $600 million. Unlike the traditional HHMI investigator programs which have relied on nominations from the investigator's institution these are open to direct application (similar to a plan they announced in a smaller scale for physician scientists last November). The grants are meant for early career investigators (between 4 and 10 years into their first assistant professor or equivalent position). So get cracking. linkurl:More info here;http://www.hhmi.org/research/competitions/investigator2008 In a time when federal research funding seems lean as linkurl:we've written about here;http://www.the-scientist.com/2006/10/1/32/1/ and the gap between haves and have-nots in biomedical research widening linkurl:as we've written about here,;http://www.the-scientist.com/2006/8/1/26/1/ it's a bit heartening to see HHMI devoting more research dollars to scientists, and doing so in a less 'clubby' way. That said they?ll only be taking applications from scientists at roughly 200 approved institutions. Josie Briggs, senior scientific officer at HHMI explained to me that the list is compiled from the institutions from which HHMI currently accepts nominations along with the top funded institution lists from the NIH and NSF. "The intent is to be broad and include all academic institutions in the country with reasonably strong biomedical research programs," says Briggs, adding that several research institutes are on the list as well. See if your institution has linkurl:made the list;http://www.hhmi.org/research/competitions/investigator2008/institutions.html ...

50 plum new grants from HHMI

The Scientist ARCHIVES

Become a Member of

Meet the Author

Brendan Maher

Related Research Resources

A Stubborn Gene, a Failed Experiment, and a New Path

Research Resources

Podcasts

Webinars

Videos

Infographics

eBooks

Advancing Drug Discovery with Complex Human In Vitro Models

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Maximizing Cancer Research Model Systems

Products

Product News

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies